The State of Reimbursement for Renal Denervation in the United States
As renal denervation is adopted across the United States for patients with uncontrolled or resistant hypertension, the dubious state of reimbursement presents a barrier to both health systems and patients seeking the procedure.
By Catherine Vanchiere, MD, MA; Tayyab Shah, MD; Debbie L. Cohen, MD; Jay Giri, MD, MPH; Brian Fulton, MD; and Taisei Kobayashi, MD
